ClearPoint Neuro IncCLPT
Price$11.45Intrinsic value$12.5810% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $42.3M+34.7% YoYTTM through 30 Jun 2026
Net Income -$34.6MTTM through 30 Jun 2026
Free Cash Flow -$31.3MTTM through 30 Jun 2026

Margins

Current
Gross Margin63.9%
EBITDA Margin-72.1%
Operating Margin-69.9%
Net Margin-81.8%

Returns

-50.7%ROE
-31.1%ROA

Balance Sheet Health

Debt / Equity2.63x
Current Ratio5.79x
Net Debt$14.1M
Cash & Equivalents$29.4M

Quality Metrics

Altman Z-Score-0.19
Piotroski F-Score3 / 9
FCF Margin-73.9%
Rule of 40-48.3
Earnings-Beat Rate0.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $37M
Diluted EPS-$1.18TTM
'21'22'23'24'25
FY2025: $-0.90

Dividend

No dividend

Capital Allocation

R&D Spend$15.8M
Capex Intensity2.6%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.